Archer J E, Magendantz M, Vega L R, Solomon F
Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA.
Mol Cell Biol. 1998 Mar;18(3):1757-62. doi: 10.1128/MCB.18.3.1757.
The yeast protein Rbl2p suppresses the deleterious effects of excess beta-tubulin as efficiently as does alpha-tubulin. Both in vivo and in vitro, Rbl2p forms a complex with beta-tubulin that does not contain alpha-tubulin, thus defining a second pool of beta-tubulin in the cell. Formation of the complex depends upon the conformation of beta-tubulin. Newly synthesized beta-tubulin can bind to Rbl2p before it binds to alpha-tubulin. Rbl2p can also bind beta-tubulin from the alpha/beta-tubulin heterodimer, apparently by competing with alpha-tubulin. The Rbl2p-beta-tubulin complex has a half-life of approximately 2.5 h and is less stable than the alpha/beta-tubulin heterodimer. The results of our experiments explain both how excess Rbl2p can rescue cells overexpressing beta-tubulin and how it can be deleterious in a wild-type background. They also suggest that the Rbl2p-beta-tubulin complex is part of a cellular mechanism for regulating the levels and dimerization of tubulin chains.
酵母蛋白Rbl2p抑制过量β-微管蛋白的有害作用的效率与α-微管蛋白相同。在体内和体外,Rbl2p都与β-微管蛋白形成不包含α-微管蛋白的复合物,从而在细胞中定义了β-微管蛋白的第二个池。复合物的形成取决于β-微管蛋白的构象。新合成的β-微管蛋白在与α-微管蛋白结合之前可以与Rbl2p结合。Rbl2p也可以从α/β-微管蛋白异源二聚体中结合β-微管蛋白,显然是通过与α-微管蛋白竞争。Rbl2p-β-微管蛋白复合物的半衰期约为2.5小时,比α/β-微管蛋白异源二聚体更不稳定。我们的实验结果解释了过量的Rbl2p如何拯救过表达β-微管蛋白的细胞以及它在野生型背景下如何有害。它们还表明Rbl2p-β-微管蛋白复合物是调节微管蛋白链水平和二聚化的细胞机制的一部分。